Publication: 47

NCCTG Phase I Trial N057K of Everolimus (RAD001) and Temozolomide in Combination with Radiation Therapy in Newly Diagnosed Glioblastoma Multiforme Patients1
      QxMD      Google Scholar   
Citation:
Int J Radiat Oncol Biol Phys vol 81 (2) 468-475
Year:
2011
Type:
Manuscript
Funding:
NCTN
Endpoint:
Primary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
1
Parents:
77   78  
Children:
None
Program:
OGC
Primary Committee:
Neuro-Onc
Sec. Committees:
   
Pharmas:
 
Grants:
U10 CA025224-25, P50 CA108961-019004, U24 CA114740-03, P50 CA108961, CA-37404, U10 CA025224-30S2, U10 CA025224-24S2, U10 CA025224-23S1, U10 CA025224-30, U24 CA114740-04, U24 CA114740-05, U10 CA025224-28, U10 CA037404, U24 CA114740, U24 CA114740-01, P50 CA108961-039004, CA-35103, CA-25224, U10 CA025224-28S3, U10 CA025224-29, U10 CA025224-30S3, U10 CA025224-24, U10 CA025224-28S1, U10 CA025224-31, CA-108961, U10 CA025224-27, P50 CA108961-049004, U10 CA025224-230004, U10 CA025224-32, P50 CA108961-029004, P50 CA108961-059004, CA 114740, U10 CA025224-23, U10 CA025224-31W1, U10 CA025224-24S1, U10 CA025224-28S2, U24 CA114740-02, U10 CA025224-220004, U10 CA025224, U10 CA025224-26, U10 CA035103  
Corr. Author:
 
Authors:
                     
Networks:
 
Study
NCCTG-N057K
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
1,2
Keywords:
glioblastoma, radiation, temozolomide, fluorodeoxyglucose PET, everolimus